PPXRD 9 Home - Pharmaceutical Powder X-ray Diffraction Symposium

PPXRD-9 Abstracts

	THE AMORPHOUS STATE: A STRUCTURAL PERSPECTIVE S. Bates, SSCI, (a division of Aptuit Consulting), West Lafayette, Indiana, U.S.A.
	THE USE OF FIELD-PORTABLE PXRD FOR THE RAPID IDENTIFICATION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AND SUBSEQUENT EXCIPIENT IDENTIFICATION AND QUANTIFICATION David F. Blake, NASA Ames Research Center, Moffett Field, CA USA Philippe Sarrazin, inXitu, Inc., Mountain View, CA USA Bradley W. Boyer, inXitu, Inc., Mountain View, CA USA Tyler C. Jennison, inXitu, Inc., Mountain View, CA USA
	X-RAY POWDER DIFFRACTION DATABASE TOOLS FOR THE PHARMACEUTICAL SCIENTIST: NEW CAPABILITIES Cyrus E. Crowder, ICDD Fangling Needham, ICDD Tim Fawcett, ICDD Justin Blanton, ICDD David Crane, ICDD Charles Weth, ICDD
	SUCCESSFUL MATERIAL IDENTIFICATION *Timothy G. Fawcett, Fangling Needham, Cyrus E. Crowder, Suri N. Kabekkodu**, ICDD, Newtown Square, PA, USA
	PXRD WITH RAMAN SPECTROSCOPY, DSC AND IR DATA Christopher Gilmore, University of Glasgow, Glasgow,UK Gordon Barr, University of Glasgow, Glasgow,UK Gordon Cunningham, University of Glasgow, Glasgow,UK
	GEOMETRY, POLARIZATION AND ABSORPTION CORRECTIONS FOR TWO-DIMENSIONAL XRD Bob B. He, Bruker AXS
	PXRD INVESTIGATION OF CHANGES IN DEHYDRATION BEHAVIOR OF 7-METHOXY-1-METHYL-5-(4-(TRIFLUOROMETHYL)PHENYL)-[1,2,4]TRIAZOLO[4,3-A]QUINOLIN-4-AMINE HYDRATE AFTER MICRONIZATION *Feirong Kang, Glenn Williams, Fred Vogt, Rachel Forcino, Jeff Brum**, GlaxoSmithKline, King of Prussia, PA 19406, USA
	XRPD CHARACTERISATION OF PHARMACEUTICAL SOLIDS - QUANTITATIVE PHASE ANALYSIS AND LOWER LIMITS OF DETECTION Arnt Kern, Bruker AXS, Karlsruhe, Germany
	INTEGRATED HYPERSPECTRAL IMAGING FOR COMPREHENSIVE MATERIALS CHARACTERIZATION Eunah Lee, Andrew Whitley, HORIBA Jobin Yvon, Inc, Edison, NJ, USA George J. Havrilla, Los Alamos National Lab, Los Alamos, NM, USA Jeremy Shaver, Eigenvector Research, Inc. Wenatchee, WA, USA
	PATENTING CRYSTALLINE FORMS OF PHARMACEUTICALS – USING SOLID STATE SCIENCE TO CLAIM FORM & SUBSTANCE Jeffrey A. Lindeman, J.A. Lindeman & Co. PLLC, McLean, VA, U.S.A.
	Solid-State Analysis of Pharmaceuticals: Solid-State NMR and PXRD Eric Munson, University of Kansas, Lawrence, KS
	POLYMORPHS in PDF-4/ORGANICS 2010 F. Needham, C.E. Crowder, T.G. Fawcett, International Centre for Diffraction Data, Newtown Square, PA
	DRUG PRODUCT CHARACTERIZATION: WHAT FORM DO I HAVE? Ann Newman, Seventh Street Development Group, Lafayette, IN USA
	ACCURATE POWDER STRUCTURAL STUDY OF PHARMACEUTICALS USING MAXIMUM ENTROPY METHOD Eiji Nishibori, Nagoya University, Nagoya, Japan
	AB INITIO CRYSTAL STRUCTURE DETERMINATION OF TWO POLYMORPHIC MODIFICATIONS OF AN ANESTHETIC AGENT, TETRACAINE HYDROCHLORIDE, USING A COMBINATION OF MOLECULAR MODELING AND SYNCHROTRON X-RAY POWDER DIFFRACTION TECHNIQUES R.J. Papoular, IRAMIS, Leon Brillouin Laboratory, Gif-sur-Yvette, France B.H. Toby, J. Doebbler, Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA N.B. Leonidov, Pavlov University of Medicine, Riazan, Russia M.-N. Petit, Institut des Matériaux de Rouen, Mont Saint-Aignan, France A.V. Dzyabchenko, Karpov Institute of Physical Chemistry, Moscow, Russia J.-M. Cense, ENSCP, Paris, France H. Allouchi, Laboratoire SPOT, Faculté de Pharmacie, Tours, France V. Agafonov, Laboratoire LEMA, Faculté de Pharmacie, Tours, France
	STRUCTURE STUDIES OF DISORDERED PHARMACEUTICAL MATERIALS BY HIGH-ENERGY X-RAY DIFFRACTION AND ATOMIC PAIR DISTRIBUTION FUNCTION ANALYSIS Valeri Petkov, Physics, CMU, Mt. Pleasant Mi 49958
	ANALYSIS OF AMORPHOUS PHASE IN HIGHLY CRYSTALLINE API BY POWDER X-RAY DIFFRACTION AND DSC *M. Davidovich, D. Hsieh, B. Sarsfield, S. Tameze, C. Vema-Varapu, B. Shekunov**, Bristol-Myers Squibb, New Brunswick, NJ, USA
	A Unique Case of Polymorph Characterization by PXRD Roxana F. Schlam, Raymond P. Scaringe, Bristol-Myers Squibb, New Brunswick, NJ
	The New World of Materials Science & Engineering: Nano & Bio Technology R.L. Snyder, School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA, USA
	EASY ACCESS TO SYNCHROTRON POWDER DIFFRACTION FOR PHARMACEUTICALS *Brian H. Toby, Matthew R. Suchomel, Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA Robert J. Papoular**, IRAMIS, Leon Brillouin Laboratory, Commissariat à l'Energie Atomique, CEN - Saclay, Gif-sur-Yvette, France
	QUANTIFICATION OF INDOMETHACIN-SACCHARIN COCRYSTALS BY POWDER X-RAY DIFFRACTION Sitaram P. Velaga, Lulea University of Technology, Lulea, Sweden Luis M. padrela, Edmundo G. Azevedo*, Instituto Superior Técnico, Lisboa, Portugal

Information on Past PPXRD Symposiums

PPXRD-8
PPXRD-7
PPXRD-6
PPXRD-5
PPXRD-4
PPXRD-3
PPXRD-2
PPXRD-1

Home | Profile | Products | Membership | Education | Resources | DXC | ToC | Contact | Search
© 1997 - 2010 by JCPDS - International Centre for Diffraction Data®
of this page and all contents. All Rights Reserved.
Please send any queries, comments, or suggestions to: webmaster@icdd.com

International Centre for Diffraction Data
12 Campus Boulevard
Newtown Square, PA 19073-3273 USA
PHONE: 610-325-9814
FAX: 610-325-9823
info@icdd.com